CTI BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	28.04	36.32	16.45	2.33	0.4
Cash & Short-Term Investments	28.04	36.32	16.45	2.33	0.4
Cash Growth	207.69%	120.87%	605.72%	483.47%	-
Accounts Receivable	0.67	0.45	0.2	-	-
Other Receivables	0.24	0.31	-	-	-
Receivables	4.6	4.75	0.2	-	-
Inventory	2.43	2.66	1.44	-	-
Prepaid Expenses	2.78	2.84	3.08	0.29	0.03
Restricted Cash	0.24	0.27	-	-	-
Total Current Assets	38.75	46.84	21.17	2.62	0.43
Property, Plant & Equipment	0.46	0.55	0.45	0.32	-
Goodwill	10.93	10.93	-	-	-
Other Intangible Assets	15.34	15.79	3.56	1.27	0.58
Other Long-Term Assets	0.06	0.05	0.06	0.01	0
Total Assets	66.15	74.89	25.25	4.22	1.02
Accounts Payable	3.1	3.5	1.83	0.42	0.14
Accrued Expenses	1.59	0.95	1.08	0.04	0.01
Short-Term Debt	3.7	3.78	-	-	-
Current Portion of Leases	0.11	0.12	0.31	0.17	-
Current Income Taxes Payable	-	0.07	0.12	-	-
Current Unearned Revenue	0.06	0.05	0.23	0.05	-
Other Current Liabilities	-	0.16	0.44	-	-
Total Current Liabilities	8.57	8.62	4.01	0.68	0.16
Long-Term Debt	28.45	28.45	-	-	-
Long-Term Leases	0.14	0.16	0.02	0.13	-
Other Long-Term Liabilities	2.97	10.81	10.79	-	-
Total Liabilities	40.13	48.04	14.81	0.81	0.16
Common Stock	0	0	0	0	0
Additional Paid-In Capital	150.37	146.75	72.64	12.38	2.8
Retained Earnings	-124.35	-119.9	-62.21	-8.88	-1.91
Comprehensive Income & Other	-	-	-	-0.1	-0.03
Shareholders' Equity	26.03	26.85	10.43	3.4	0.86
Total Liabilities & Equity	66.15	74.89	25.25	4.22	1.02
Total Debt	32.4	32.51	0.33	0.3	-
Net Cash (Debt)	-4.36	3.81	16.12	2.03	0.4
Net Cash Growth	-	-76.35%	693.49%	408.60%	-
Net Cash Per Share	-0.12	0.12	0.73	0.18	1.02
Filing Date Shares Outstanding	45.54	42.91	28.29	0.77	0.39
Total Common Shares Outstanding	43.17	42.79	27.62	0.77	0.39
Working Capital	30.18	38.21	17.17	1.94	0.28
Book Value Per Share	0.60	0.63	0.38	4.41	2.20
Tangible Book Value	-0.25	0.13	6.88	2.13	0.28
Tangible Book Value Per Share	-0.01	0.00	0.25	2.77	0.71
Machinery	-	0.19	0.14	0.03	-
Leasehold Improvements	-	0.18	-	-	-

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q